Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study
Authors:
- Man WangMWMan Wang
- Jian-Hua TongJTJian-Hua Tong
- Gang ZhuGZGang Zhu
- Guang-Ming LiangGLGuang-Ming Liang
- Hong-Fei YanHYHong-Fei Yan
- Xiu-Zhen WangXWXiu-Zhen Wang
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 138 (1) , 54-57
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research Fund of Liaoning Science and Technology Agency, China
- 2011225020
This publication has 19 references indexed in Scilit:
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2008
- Factors Associated With Diabetes Onset During Metformin Versus Placebo Therapy in the Diabetes Prevention ProgramDiabetes, 2007
- Effects of pioglitazone and metformin on β-cell function in nondiabetic subjects at high risk for type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Acidose lactique et metformineAnnales Françaises d'Anesthésie et de Réanimation, 2006
- Metformin-associated lactic acidosis treated with continuous renal replacement therapyClinical Therapeutics, 2006
- Metformin-related vitamin B12 deficiencyAge and Ageing, 2006
- A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight GainAmerican Journal of Psychiatry, 2005
- H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic DrugsNeuropsychopharmacology, 2003
- Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patientsInternational Journal of Neuropsychopharmacology, 1999
- The Effect of Metformin on the Metabolic Abnormalities Associated With Upper-Body Fat Distribution. BIGPRO Study GroupDiabetes Care, 1996